XML 32 R81.htm IDEA: XBRL DOCUMENT
v2.4.0.8

18. Pro Forma Financials for Acquisition of Canterbury and Hygeia (Details A) (USD $) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012
Cost of revenues | $ 0 | $ 0 | $ 0 | $ 235,803
Gross profit | 0 | 0 | 71,667 | 138,739
Operating expenses |  |  |  |
General, administrative, research and development | 611,845 | 624,674 | 2,008,118 | 4,570,161
Impairment of intangible assets |  |  | 1,935,621 | 1,423,844
Warrants, options and stock | 149,885 | 1,316,148 | 4,228,317 | 3,643,662
Fair value of common stock exchanged for warrants |  |  | 3,069,792 | 0
Legal and professional services | 131,686 | 143,103 | 1,071,392 | 2,128,898
Depreciation and amortization | 478,104 | 8,687 | 675,757 | 164,043
Total operating expenses | 1,371,520 | 2,092,612 | 12,988,997 | 11,930,608
Loss from operations | (1,371,520) | (2,092,612) | (12,917,330) | (11,791,869)
Other (income)/expenses |  |  |  |
(Gain)/loss on adjustments to fair value of derivative liability | 0 | 236,850 | (8,980,077) | (6,907,748)
Gain on extinguishment of derivative liability |  |  | (1,635,967) | 0
Other (income)/expense | (49,639) | (2,564) | (71,631) | 379,188
Interest expense | 58,294 | 22,971 | 228,294 | 167,894
Total other income | 8,655 | 257,257 | (10,459,381) | (4,942,054)
Net loss | (1,380,175) | (2,476,780) | (2,457,949) | (6,849,815)
Net loss attributed to non-controlling interests |  |  | (6,401) | (19,079)
Net loss attributed to RestorGenex Corporation |  |  | (2,464,350) | (6,868,894)
Preferred dividends | $ 0 | $ 124,375 | $ 171,625 | $ 497,167
Net loss attributable to RestorGenex Corporation common shareholders | (1,380,175) | (2,601,155) | (2,635,975) | (7,366,061)
Basic and diluted loss per share | $ (0.23) | $ (2.91) | $ (1.00) | $ (8.16)
Pro Forma Adjustments for Canterbury and Hygeia (b) |  |  |  |
Revenues |  |  | 127,167 |
Cost of revenues |  |  | 89,387 |
Gross profit |  |  | 37,780 |
Operating expenses |  |  |  |
General, administrative, research and development |  |  | 265,260 |
Impairment of intangible assets |  |  | 0 |
Warrants, options and stock |  |  | 0 |
Fair value of common stock exchanged for warrants |  |  | 0 |
Legal and professional services |  |  | 326,646 |
Depreciation and amortization |  |  | 14,781 |
Total operating expenses |  |  | 606,687 |
Other (income)/expenses |  |  |  |
(Gain)/loss on adjustments to fair value of derivative liability |  |  | 0 |
Gain on extinguishment of derivative liability |  |  | 0 |
Other (income)/expense |  |  | 0 |
Interest expense |  |  | 20,267 |
Total other income |  |  | 20,267 |
Net loss |  |  | (589,174) |
Net loss attributed to non-controlling interests |  |  | 0 |
Net loss attributed to RestorGenex Corporation |  |  | (589,174) |
Preferred dividends |  |  | $ 0 |
Net loss attributable to RestorGenex Corporation common shareholders |  |  | (589,174) |
Other Pro Forma Adjustments |  |  |  |
Revenues |  |  | 0 |
Cost of revenues |  |  | 0 |
Gross profit |  |  | 0 |
Operating expenses |  |  |  |
General, administrative, research and development |  |  | 503,732 |
Impairment of intangible assets |  |  | 0 |
Warrants, options and stock |  |  | 0 |
Fair value of common stock exchanged for warrants |  |  | 0 |
Legal and professional services |  |  | 0 |
Depreciation and amortization |  |  | 659,958 |
Total operating expenses |  |  | 1,163,690 |
Other (income)/expenses |  |  |  |
(Gain)/loss on adjustments to fair value of derivative liability |  |  | 0 |
Gain on extinguishment of derivative liability |  |  | 0 |
Other (income)/expense |  |  | 0 |
Interest expense |  |  | 0 |
Total other income |  |  | 0 |
Net loss |  |  | (1,163,690) |
Net loss attributed to non-controlling interests |  |  | 0 |
Net loss attributed to RestorGenex Corporation |  |  | (1,163,690) |
Preferred dividends |  |  | $ 0 |
Net loss attributable to RestorGenex Corporation common shareholders |  |  | (1,163,690) |
Basic and fully-diluted weighted average shares outstanding |  |  | 1,014,623 |
Pro Forma Combined |  |  |  |
Revenues |  |  | 198,834 |
Cost of revenues |  |  | 89,387 |
Gross profit |  |  | 109,447 |
Operating expenses |  |  |  |
General, administrative, research and development |  |  | 2,777,110 |
Impairment of intangible assets |  |  | 1,935,621 |
Warrants, options and stock |  |  | 4,228,317 |
Fair value of common stock exchanged for warrants |  |  | 3,069,792 |
Legal and professional services |  |  | 1,398,038 |
Depreciation and amortization |  |  | 1,350,496 |
Total operating expenses |  |  | 14,759,374 |
Other (income)/expenses |  |  |  |
(Gain)/loss on adjustments to fair value of derivative liability |  |  | (8,980,077) |
Gain on extinguishment of derivative liability |  |  | (1,183,093) |
Other (income)/expense |  |  | (524,505) |
Interest expense |  |  | 248,561 |
Total other income |  |  | (10,439,114) |
Net loss |  |  | (4,210,813) |
Net loss attributed to non-controlling interests |  |  | (6,401) |
Net loss attributed to RestorGenex Corporation |  |  | (4,217,214) |
Preferred dividends |  |  | $ 171,625 |
Net loss attributable to RestorGenex Corporation common shareholders |  |  | (4,388,839) |
Basic and diluted loss per share |  |  | $ (1.20) |
Basic and fully-diluted weighted average shares outstanding |  |  | 3,661,226 |
RestorGenex |  |  |  |
Revenues |  |  | 71,667 |
Cost of revenues |  |  | 0 |
Gross profit |  |  | 71,667 |
Operating expenses |  |  |  |
General, administrative, research and development |  |  | 2,008,118 |
Impairment of intangible assets |  |  | 1,935,621 |
Warrants, options and stock |  |  | 4,228,317 |
Fair value of common stock exchanged for warrants |  |  | 3,069,792 |
Legal and professional services |  |  | 1,071,392 |
Depreciation and amortization |  |  | 675,757 |
Total operating expenses |  |  | 12,988,997 |
Other (income)/expenses |  |  |  |
(Gain)/loss on adjustments to fair value of derivative liability |  |  | (8,980,077) |
Gain on extinguishment of derivative liability |  |  | (1,183,093) |
Other (income)/expense |  |  | (524,505) |
Interest expense |  |  | 228,294 |
Total other income |  |  | (10,459,381) |
Net loss |  |  | (2,457,949) |
Net loss attributed to non-controlling interests |  |  | (6,401) |
Net loss attributed to RestorGenex Corporation |  |  | (2,464,350) |
Preferred dividends |  |  | $ 171,625 |
Net loss attributable to RestorGenex Corporation common shareholders |  |  | $ (2,635,975) |
Basic and diluted loss per share |  |  | $ (1.00) |
Basic and fully-diluted weighted average shares outstanding |  |  | 2,646,603 |

X
- Definition Fair value of common stock exchanged for warrants + References No definition available. + Details
Name: | RESX_FairValueOfCommonStockExchangedForWarrants
Namespace Prefix: | RESX_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Warrants, options and stock compensation + References No definition available. + Details
Name: | RESX_WarrantExpenseAndFairValueChargeForStockSales
Namespace Prefix: | RESX_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 + Details
Name: | us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 + Details
Name: | us-gaap_CostOfRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (a),(c),(d),(e) -URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959 + Details
Name: | us-gaap_DerivativeGainLossOnDerivativeNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. + References No definition available. + Details
Name: | us-gaap_EarningsPerShareBasicAndDiluted
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill. + References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetImpairment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 + Details
Name: | us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 + Details
Name: | us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Article 5 + Details
Name: | us-gaap_NonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_NonoperatingIncomeExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. + References No definition available. + Details
Name: | us-gaap_OperatingExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_OperatingExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate dividends declared during the period for each share of preferred stock outstanding. + References No definition available. + Details
Name: | us-gaap_PreferredStockDividendsPerShareDeclared
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.2(a),(b),(c),(d)) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section 45 -Paragraph 3 -Subparagraph (k) -URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849 + Details
Name: | us-gaap_ProfessionalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). + References No definition available. + Details
Name: | us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration